Item 5.07 Submission of Matters to a Vote of Security Holders.
OnJune 2, 2021 ,Adamas Pharmaceuticals, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting"). Set forth below is a brief description of each matter considered and voted upon at the Annual Meeting, together with the final tally of the number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes as to each such matter, as applicable, including a separate tabulation with respect to each of the three directors. A more complete description of each matter is set forth in the Company's Definitive Proxy Statement on Schedule 14A filed with theU.S. Securities and Exchange Commission onApril 19, 2021 . Proposal No. 1 - Election of DirectorsThe Company's stockholders elected the three Class I director nominees to the Company's Board of Directors to hold office until the 2024 Annual Meeting of Stockholders or until their successors are elected. The vote was as follows: Class I Director Nominees Votes For Votes Withheld Broker Non-Votes Martha J. Demski 24,341,973 1,540,649 8,258,250 William W. Ericson 24,144,704 1,737,918 8,258,250 Spyridon Papapetropoulos, M.D., Ph.D. 24,497,736 1,384,886 8,258,250 Proposal No. 2 - Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. The vote was as follows:
Votes For Votes Against Abstentions Broker Non-Votes
22,467,423 3,372,660 42,539 8,258,250 Proposal No. 3 - Ratification of the selection of independent registered accounting firm The Company's stockholders ratified the selection ofPricewaterhouseCoopers LLC as the independent registered public accounting firm of the Company for its fiscal year endingDecember 31, 2021 . The vote was as follows: Votes For Votes Against Abstentions Broker Non-Votes 33,669,250 339,726 131,896 - 2
--------------------------------------------------------------------------------
© Edgar Online, source